Literature DB >> 10749730

Myofibrillar disruption in hypocontractile myocardium showing perfusion-contraction matches and mismatches.

A J Sherman1, F J Klocke, R S Decker, M L Decker, K A Kozlowski, K R Harris, S Hedjbeli, Y Yaroshenko, S Nakamura, M A Parker, P A Checchia, D B Evans.   

Abstract

Chronically instrumented dogs underwent 2- or 5-h regional reductions in coronary flow that were followed, respectively, by balanced reductions in myocardial contraction and O(2) consumption ("hibernation") and persistently reduced contraction despite normal myocardial O(2) consumption ("stunning"). Previously unidentified myofibrillar disruption developed during flow reduction in both experimental models and persisted throughout the duration of reperfusion (2-24 h). Aberrant perinuclear aggregates that resembled thick filaments and stained positively with a monoclonal myosin antibody were present in 34 +/- 3.8% (SE) and 68 +/- 5.9% of "hibernating" and "stunned" subendocardial myocytes in areas subjected to flow reduction and in 16 +/- 2.5% and 44 +/- 7.4% of subendocardial myocytes in remote areas of the same ventricles. Areas of myofibrillar disruption also showed glycogen accretion and unusual heterochromatin clumping adjacent to the inner nuclear envelope. The degrees of flow reduction employed were sufficient to reduce regional myofibrillar creatine kinase activity by 25-35%, but troponin I degradation was not evident. The observed changes may reflect an early, possibly reversible, phase of the myofibrillar loss characteristic of hypocontractile myocardium in patients undergoing revascularization.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2000        PMID: 10749730     DOI: 10.1152/ajpheart.2000.278.4.H1320

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  14 in total

Review 1.  Hibernating myocardium.

Authors:  R Schulz; G Heusch
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

Review 2.  Molecular and cellular basis of viable dysfunctional myocardium.

Authors:  Marina Bayeva; Konrad Teodor Sawicki; Javed Butler; Mihai Gheorghiade; Hossein Ardehali
Journal:  Circ Heart Fail       Date:  2014-07       Impact factor: 8.790

Review 3.  Top-down mass spectrometry of cardiac myofilament proteins in health and disease.

Authors:  Ying Peng; Serife Ayaz-Guner; Deyang Yu; Ying Ge
Journal:  Proteomics Clin Appl       Date:  2014-08       Impact factor: 3.494

4.  Immunological and histopathological changes in the atrial tissue during and after cardiopulmonary bypass.

Authors:  N Alotti; J Sipos; E Roth; G Kecskés; J Simon; A Rashed; I Kassai
Journal:  Exp Clin Cardiol       Date:  2001

Review 5.  Chronic hibernation and chronic stunning: a continuum.

Authors:  J M Canty; J A Fallavollita
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

6.  The structural characteristics of the heart ventricle of the African lungfish Protopterus dolloi: freshwater and aestivation.

Authors:  José M Icardo; Daniela Amelio; Filippo Garofalo; Elvira Colvee; Maria C Cerra; Wai P Wong; Bruno Tota; Yuen K Ip
Journal:  J Anat       Date:  2008-08       Impact factor: 2.610

Review 7.  Effects of brief ischemia and reperfusion on the myocardium and the role of nitric oxide.

Authors:  Christopher S R Baker; Sanjay Kumar; Ornella E Rimoldi
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

Review 8.  Novel mechanisms mediating stunned myocardium.

Authors:  Song-Jung Kim; Christophe Depre; Stephen F Vatner
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

Review 9.  TNNI1, TNNI2 and TNNI3: Evolution, regulation, and protein structure-function relationships.

Authors:  Juan-Juan Sheng; Jian-Ping Jin
Journal:  Gene       Date:  2015-10-23       Impact factor: 3.688

Review 10.  Diagnosis and Therapy of Atrial Fibrillation: The Past, The Present and The Future.

Authors:  Denise M S van Marion; Eva A H Lanters; Marit Wiersma; Maurits A Allessie; Bianca B J J M Brundel; Natasja M S de Groot
Journal:  J Atr Fibrillation       Date:  2015-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.